Morpholino

MO2-dmrta2

ID

ZDB-MRPHLNO-150216-1

Name

MO2-dmrta2

Previous Names

None

Target

dmrta2 (1)

Sequence

5' - AACGTTTCTACTTACCAGAGTTTGA - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

Splice-blocking MO.

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO2-dmrta2

No data available

Phenotype

Phenotype resulting from MO2-dmrta2

No data available

Phenotype of all Fish created by or utilizing MO2-dmrta2

Phenotype	Fish	Conditions	Figures
adenohypophysis has extra parts of type follicle stimulating hormone secreting cell, abnormal	WT + MO2-dmrta2 + MO3-dmrta2	standard conditions	Fig. 6 from Graf et al., 2015
rostral pars anterior prolactin secreting cell dispersed, abnormal	WT + MO2-dmrta2 + MO3-dmrta2	standard conditions	Fig. 7 from Graf et al., 2015
adenohypophysis has fewer parts of type adrenocorticotropic hormone secreting cell, abnormal	WT + MO2-dmrta2 + MO3-dmrta2	standard conditions	Fig. 4, Fig. 6 from Graf et al., 2015
adenohypophysis apoptotic process increased occurrence, abnormal	WT + MO2-dmrta2 + MO3-dmrta2	standard conditions	Fig. 7 from Graf et al., 2015
prolactin secreting cell development decreased process quality, abnormal	WT + MO2-dmrta2 + MO3-dmrta2	standard conditions	Fig. 7 from Graf et al., 2015
adenohypophysis has fewer parts of type prolactin secreting cell, abnormal	WT + MO2-dmrta2 + MO3-dmrta2	standard conditions	Fig. 7 from Graf et al., 2015
adenohypophysis corticotropin hormone secreting cell differentiation decreased occurrence, abnormal	WT + MO2-dmrta2 + MO3-dmrta2	standard conditions	Fig. 4, Fig. 6 from Graf et al., 2015
adenohypophysis corticotropin hormone secreting cell differentiation decreased occurrence, abnormal	WT + MO2-dmrta2 + MO3-dmrta2 + MO4-tp53	standard conditions	Fig. 4 from Graf et al., 2015
adenohypophysis has fewer parts of type adrenocorticotropic hormone secreting cell, abnormal	WT + MO2-dmrta2 + MO3-dmrta2 + MO4-tp53	standard conditions	Fig. 4 from Graf et al., 2015

Citations